With this issue we welcome three members to the distinguished editorial advisory board that has guided Contemporary OB/GYN since its inception.
Yalda Afshar, MD, PhD; Christine Isaacs, MD; and Laura Riley, MD begin their time in lending expertise to the content in these pages and online. You can read more about each remarkable scientist here.
We hope you also will find the content in this issue rich and informative. The Society for Maternal-Fetal Medicine (SMFM) shares its Consult Series #50 on Activity Restriction in obstetric management. Editor-in-Chief Catherine Y. Spong, MD, dedicates her editorial to the topic with an endorsement to put activity restriction to bed – her pun fully intended – as research now is available to provide guidance for practitioners recommending against its routine use.
Practitioners continue to navigate health care in a pandemic, conducting much patient communication virtually. Four doctors from Yale—Linda L. Fan, MD, FACOG; Shefali R. Pathy, MD, MPH; Julia Cron, MD; and Sangini S. Sheth, MD, MPH—offer their guidance on managing the Well Woman visit via telehealth.
In the first article of a two-part series, Amanda Kallen, MD, and Sandra Ann Carson, MD, offer a thorough guide to diagnosing an infertile couple. Watch for next month’s article as well, where they provide a guide for treatment.
Ronald J. Wapner, MD, makes a case for improved carrier screening. Ideally, women of reproductive age would be offered carrier screening before conception to maximize the subsequent reproductive options for carrier couples, he says.
Please let us know what you think of this content; reader feedback is invited by emailing Senior Editor Angie DeRosa at aderosa@mjhlifesciences.com.
__
Mike Hennessy, Sr.
Chairman and Founder, MJH Life Sciences
SART data indicates rise in IVF use in 2022
April 24th 2024Dive into the latest statistics from the Society for Assisted Reproductive Technology, revealing a 6% increase in in vitro fertilization cycles and a surge in egg freezing, amidst a landscape of rising fertility service demand and evolving clinical practices.
Read More
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More